Holding(s) in Company
| |
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | E-Therapeutics plc |
2 Reason for the notification (please tick the appropriate box or boxes): | ||
An acquisition or disposal of voting rights | ✓ | |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |
An event changing the breakdown of voting rights |
| |
Other (please specify): |
|
|
3. Full name of person(s) subject to the notification obligation: iii | Rupert Labrum |
4. Full name of shareholder(s) (if different from 3.): iv |
|
5. Date of the transaction and date on which the threshold is crossed or reached: v | 17/09/2019 |
6. Date on which issuer notified: | 17/09/2019 |
7. Threshold(s) that is/are crossed or reached: vi, vii | 6.00% |
8. Notified details: | |||||||
A: Voting rights attached to shares viii, ix | |||||||
Class/type of
| Situation previous | Resulting situation after the triggering transaction | |||||
Number | Number | Number | Number of voting | % of voting rights x | |||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||
GB00B2823H99
| 13449017 | 13449017 | 17162547 | 17162547 |
| 6.39% |
|
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction | ||||
Type of financial | Expiration | Exercise/ | Number of voting | % of voting |
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financial | Exercise | Expiration | Exercise/ | Number of voting | % of voting rights xix, xx | |
|
|
|
|
| Nominal | Delta |
|
|
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
17162547 | 6.39% |
9. Chain of controlled undertakings through which the voting rights and/or the |
|
Proxy Voting: | |
10. Name of the proxy holder: |
|
11. Number of voting rights proxy holder will cease to hold: |
|
12. Date on which proxy holder will cease to hold voting rights: |
|
13. Additional information: |
|
14. Contact name: | Rupert Labrum |
15. Contact telephone number: |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.